Canada: The Impact Of Québec's Bill 92 On Arrangements Between Manufacturers And Pharmacies, And Patient Support

On December 6, 2016 the Québec National Assembly passed Bill 92, "An Act to extend the powers of the Régie de l'assurance maladie du Québec, regulate commercial practices relating to prescription drugs and protect access to voluntary termination of pregnancy services."

In order to better oversee the various areas under the Régie de l'Assurance Maladie du Québec (RAMQ) Bill 92 has increased the RAMQ's capacities. Bill 92 includes prohibitions on commercial practices between drug manufacturers, wholesalers, pharmacies, and manufacturers' ability to offer financial assistance or reimbursement to patients. Concerning products on the RAMQ List of Medications, the bill contains restrictions to the reimbursement of drug costs by a manufacturer and to possible permissible contractual arrangements made between a manufacturer, wholesaler and a pharmacy. Most of the provisions of Bill 92 are now in force, with some important exceptions.

What You Need To Know

  • Manufacturers and wholesalers are barred from paying or reimbursing (in whole or in part) the price of listed drug products on behalf of a patient, with an exception for "humanitarian" supply. This provision will come into force along with a regulation that will set out the criteria to qualify for the exception of a humanitarian reason.
  • Manufacturers, wholesalers and pharmacies have new restrictions on exclusivity or preferred arrangements regarding the purchase of listed drugs.
  • Bill 92 permits RAMQ to delist a drug product in several circumstances, including if
    • a manufacturer fails to comply with its obligations under regulation or in an agreement with the ministry,
    • a competing drug becomes subject to a listing agreement with the ministry, or
    • delisting is recommended by the Institut national d'excellence en santé et en services sociaux (INESSS).

Loyalty Cards and Patient Support

Under Bill 92, manufacturers are unable to pay/reimburse all or a portion of the price of a drug that is covered by the provincial health plan. Accordingly, the provision would prohibit brand loyalty cards where a patient is dispensed a brand product and the manufacturer pays the difference in cost between the brand and generic product. The manufacturer would also be unable to provide co-pay assistance, bridge funding or other financial support. The provision would be subject to exception for "humanitarian" reasons which will be set out in a regulation to the Act. These prohibitions will come into force on the date that the "humanitarian" regulations are put into place. The government has not provided an indication of when this regulation may be enacted.

Commercial Arrangements

Under Bill 92, certain commercial arrangements between manufacturers, wholesalers and pharmacies are prohibited, including the following:

  • A manufacturer cannot require that a pharmacist buy drugs exclusively from the manufacturer, nor can they directly or indirectly encourage or require a pharmacist to sell a particular brand of drug preferentially
  • Manufacturers cannot directly or indirectly grant to or receive from a pharmacist any advantages relating to the sale of drugs, except as authorized by regulation. For example, authorized benefits/professional allowances that are allowed under existing Québec laws would continue to be permitted.

These prohibitions could impact preferred provider agreements or specialized distribution arrangements in Québec.

Delisting of Drugs

Bill 92 permits RAMQ to delist a drug from the List of Medications in the following circumstances:

  1. The manufacturer fails to comply with a condition or commitment prescribed by regulation, a provision of a listing agreement or contract entered into following a call for tenders.
  2. The selling price guaranteed by the manufacturer is higher than the maximum amount payable by the basic drug insurance plan.
  3. A competing drug is the subject of a listing agreement.
  4. Either the l'Institut national d'excellence en santé et en services sociaux (INESSS) recommends or the Minister considers it in the public interest to do so.

The provisions are important for innovative manufacturers to keep in mind when negotiating a product listing agreement, as RAMQ will assert that it has the power to delist a drug if a lower cost alternative becomes available.

Pharmacist Obligations

To support drug pricing transparency, as of September 15, 2017, pharmacists will have the obligation to provide greater disclosure to patients regarding fees relating to drug dispensing. A patient must be given a receipt that separately specifies the price of the drug, the amount that is covered by the public drug insurance plan, the wholesaler's margin, the pharmacist's professional fees, and the amount that must be paid by the patient.

Increased Enforcement Powers

Under the new legislation, RAMQ has enhanced enforcement powers with respect to the collection of unlawful rebates paid by .drug manufacturers and wholesalers to pharmacies. Once the enforcement provisions come into force on March 7, 2017, RAMQ will also have the authority to demand a further administrative monetary penalty of 15% of the amount of any such rebate. The fines for a drug manufacturer's or wholesaler's non-compliance with the new regulations can be up to $1 million and can be doubled for repeated offences.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions